FDA Notification Regarding Isoxsuprine Hydrochloride Drug Products

[FDA]

On July 15, 2020, FDA announced the final decision of the Commissioner of Food and Drugs, that Vasodilan containing isoxsuprine hydrochloride lacked substantial evidence, consisting of adequate and well-controlled studies, to be effective for specific indications.


Baca selengkapnya di : http://www.fda.gov...